IL-32 expression is an independent prognostic marker for gastric cancer

Cohort Study Based on the Seventh Edition of the TNM Classification for Gastric Cancer: Proposal of a New Staging System

(2011) Viktoria S. Warneke et al.   JOURNAL OF CLINICAL ONCOLOGY

Microenvironment-Derived IL-1 and IL-17 Interact in the Control of Lung Metastasis

(2011) Y. Carmi et al.   JOURNAL OF IMMUNOLOGY

Roles of inflammatory cytokines in the progression of gastric cancer: friends or foes?

(2010) Hironori Tsujimoto et al.   Gastric Cancer

Expression of IL-32 in Human Lung Cancer Is Related to the Histotype and Metastatic Phenotype

(2009) Carlo Sorrentino et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Molecular characterization of IL-32 in human endothelial cells

(2009) Hanako Kobayashi et al.   CYTOKINE

Suppressing IL-32 in monocytes impairs the induction of the proinflammatory cytokines TNFα and IL-1β

(2009) Jaewoo Hong et al.   CYTOKINE

Interleukin-32 Expression in the Pancreas

(2009) Atsushi Nishida et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

IL-32, a Novel Proinflammatory Cytokine in Chronic Obstructive Pulmonary Disease

(2008) Fiorella Calabrese et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE